CLOV
Price
$4.32
Change
+$0.08 (+1.89%)
Updated
Jan 22, 04:59 PM (EDT)
Capitalization
381.23M
41 days until earnings call
NEUE
Price
$7.34
Change
-$0.03 (-0.41%)
Updated
Jan 22, 04:58 PM (EDT)
Capitalization
52M
Ad is loading...

CLOV vs NEUE

Header iconCLOV vs NEUE Comparison
Open Charts CLOV vs NEUEBanner chart's image
Clover Health Investments
Price$4.32
Change+$0.08 (+1.89%)
Volume$80.17K
Capitalization381.23M
NeueHealth
Price$7.34
Change-$0.03 (-0.41%)
Volume$276
Capitalization52M
CLOV vs NEUE Comparison Chart
Loading...
CLOV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NEUE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CLOV vs. NEUE commentary
Jan 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLOV is a Hold and NEUE is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Jan 23, 2025
Stock price -- (CLOV: $4.24 vs. NEUE: $7.37)
Brand notoriety: CLOV and NEUE are both not notable
Both companies represent the Managed Health Care industry
Current volume relative to the 65-day Moving Average: CLOV: 130% vs. NEUE: 38%
Market capitalization -- CLOV: $381.23M vs. NEUE: $52M
CLOV [@Managed Health Care] is valued at $381.23M. NEUE’s [@Managed Health Care] market capitalization is $52M. The market cap for tickers in the [@Managed Health Care] industry ranges from $451.47B to $0. The average market capitalization across the [@Managed Health Care] industry is $68.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLOV’s FA Score shows that 0 FA rating(s) are green whileNEUE’s FA Score has 1 green FA rating(s).

  • CLOV’s FA Score: 0 green, 5 red.
  • NEUE’s FA Score: 1 green, 4 red.
According to our system of comparison, NEUE is a better buy in the long-term than CLOV.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLOV’s TA Score shows that 3 TA indicator(s) are bullish while NEUE’s TA Score has 5 bullish TA indicator(s).

  • CLOV’s TA Score: 3 bullish, 4 bearish.
  • NEUE’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, NEUE is a better buy in the short-term than CLOV.

Price Growth

CLOV (@Managed Health Care) experienced а +13.37% price change this week, while NEUE (@Managed Health Care) price change was +0.14% for the same time period.

The average weekly price growth across all stocks in the @Managed Health Care industry was -0.64%. For the same industry, the average monthly price growth was +11.23%, and the average quarterly price growth was +10.20%.

Reported Earning Dates

CLOV is expected to report earnings on May 13, 2025.

NEUE is expected to report earnings on Aug 09, 2023.

Industries' Descriptions

@Managed Health Care (-0.64% weekly)

Managed healthcare industry focuses on providing health/medical and disability insurance plans, generally intended to reduce the cost of for-profit health care. The insurance products might be provided through employer-paid (fully or partly) insurance and benefit programs, or through Medicare/Medicaid. Some of the largest providers of managed health care include Aetna, Humana Inc., and Cigna, and UnitedHealthcare.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CLOV($381M) has a higher market cap than NEUE($52M). CLOV YTD gains are higher at: 34.603 vs. NEUE (-0.674).
CLOVNEUECLOV / NEUE
Capitalization381M52M733%
EBITDA-210.84MN/A-
Gain YTD34.603-0.674-5,135%
P/E RatioN/AN/A-
Revenue2.03BN/A-
Total Cash243MN/A-
Total Debt4.66MN/A-
TECHNICAL ANALYSIS
Technical Analysis
CLOVNEUE
RSI
ODDS (%)
Bearish Trend 15 days ago
83%
Bearish Trend 15 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 15 days ago
79%
Bearish Trend 15 days ago
90%
Momentum
ODDS (%)
Bullish Trend 15 days ago
74%
Bullish Trend 15 days ago
78%
MACD
ODDS (%)
N/A
Bullish Trend 15 days ago
75%
TrendWeek
ODDS (%)
Bullish Trend 15 days ago
82%
Bullish Trend 15 days ago
77%
TrendMonth
ODDS (%)
Bullish Trend 15 days ago
84%
Bullish Trend 15 days ago
71%
Advances
ODDS (%)
Bullish Trend 15 days ago
81%
Bullish Trend 15 days ago
79%
Declines
ODDS (%)
Bearish Trend 21 days ago
84%
Bearish Trend 20 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 15 days ago
84%
Bearish Trend 15 days ago
90%
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Ad is loading...
CLOV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NEUE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
EGOIX18.810.18
+0.97%
Allspring Large Cap Core Inst
PSLGX144.131.35
+0.95%
Putnam Sustainable Leaders R6
PHLAX33.80N/A
N/A
PGIM Jennison Health Sciences A
PSSRX23.82N/A
N/A
PGIM Jennison Financial Services R
AZEMX10.97N/A
N/A
Alger Emerging Markets Z

CLOV and

Correlation & Price change

A.I.dvisor tells us that CLOV and ALHC have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CLOV and ALHC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLOV
1D Price
Change %
CLOV100%
+3.92%
ALHC - CLOV
29%
Poorly correlated
-0.07%
NEUE - CLOV
24%
Poorly correlated
-1.07%
OSCR - CLOV
18%
Poorly correlated
-1.57%
MOH - CLOV
18%
Poorly correlated
+3.92%
CNC - CLOV
18%
Poorly correlated
+2.27%
More

NEUE and

Correlation & Price change

A.I.dvisor tells us that NEUE and CLOV have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NEUE and CLOV's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NEUE
1D Price
Change %
NEUE100%
-1.07%
CLOV - NEUE
24%
Poorly correlated
+3.92%
CVS - NEUE
21%
Poorly correlated
+1.01%
UNH - NEUE
21%
Poorly correlated
+2.99%
CI - NEUE
21%
Poorly correlated
+1.62%
OSCR - NEUE
21%
Poorly correlated
-1.57%
More